Regenxbio Inc (NASDAQ: RGNX) is -13.07% lower on its value in year-to-date trading and has touched a low of $5.62 and a high of $23.14 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RGNX stock was last observed hovering at around $6.55 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $6.72, the stock is 0.75% and -8.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.6 million and changing 2.60% at the moment leaves the stock -34.19% off its SMA200. RGNX registered -69.43% loss for a year compared to 6-month loss of -47.13%. The firm has a 50-day simple moving average (SMA 50) of $7.3228 and a 200-day simple moving average (SMA200) of $10.2117.
The stock witnessed a -6.67% gain in the last 1 month and extending the period to 3 months gives it a -31.15%, and is 5.99% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.69% over the week and 7.22% over the month.
Regenxbio Inc (RGNX) has around 344 employees, a market worth around $336.58M and $84.33M in sales. Profit margin for the company is -283.19%. Distance from 52-week low is 19.57% and -70.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-57.85%).
with sales reaching $128.75M over the same period.The EPS is expected to grow by 96.20% this year, but quarterly earnings will post 281.93% year-over-year. Quarterly sales are estimated to grow 724.16% in year-over-year returns.
Regenxbio Inc (RGNX) Top Institutional Holders
254.0 institutions hold shares in Regenxbio Inc (RGNX), with institutional investors hold 94.47% of the company’s shares. The shares outstanding are 49.53M, and float is at 44.72M with Short Float at 14.04%. Institutions hold 87.56% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.61 million shares valued at $100.73 million. The investor’s holdings represent 18.8252% of the RGNX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.11 million shares valued at $59.83 million to account for 11.1818 of the shares outstanding. The other top investors are REDMILE GROUP, LLC which holds 4.57 million shares representing 9.0311% and valued at over $53.47 million, while STATE STREET CORP holds 6.2826 of the shares totaling 2.87 million with a market value of $33.62 million.
Regenxbio Inc (RGNX) Insider Activity
#####
Regenxbio Inc disclosed in a document filed with the SEC on Oct 01 ’24 that KARABELAS ARGERIS N (Director) sold a total of 10,000 shares of the company’s common stock. The trade occurred on Oct 01 ’24 and was made at $10.11 per share for $0.1 million. Following the transaction, the insider now directly holds 11286.0 shares of the RGNX stock.
Still, SEC filings show that on Sep 03 ’24, KARABELAS ARGERIS N (Director) disposed off 10,000 shares at an average price of $11.56 for $0.12 million. The insider now directly holds 11,286 shares of Regenxbio Inc (RGNX).
